ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 726

Associates of Pleurisy of Pericarditis in Systemic Lupus Erythematosus (SLE)

Seungwon Ryu1 and Michelle Petri2, 1Konkuk University School of Medicine, Seoul, South Korea, 2Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Serositis is one of the classification criteria for systemic lupus erythematosus and a common type of extra renal flare. Comparison of associates of pleurisy and pericarditis separately has not been previously done in Caucasians and African Americans.

Methods: 2,390 SLE patients in the Hopkins Lupus Cohort were analyzed for demographic, clinical and serologic associates of pleurisy or pericarditis, defined using the SELENA revision of the SLE Disease Activity Index (SLEDAI). We reported associates with a p-value of less than 0.05 for both and for pleurisy or pericarditis separately.

Results: 43% had pleurisy and 22% had pericarditis. African-American ethnicity was associated with pericarditis. Renal lupus and seizure were associated only with pericarditis, whereas arthritis was associated only with pleurisy. Only pericarditis was associated with anti-RNP and anti-Sm. Both pleurisy and pericarditis are associated with anti-dsDNA and low complement.

Table 1. Demographic Characteristics Associated with Serositis in SLE (p<0.0001)

Characteristics

Subgroup

Negative

Positive

OR

95% CI

P-value

Factors significantly associated with only Pericarditis

African-American ethnicity

Pericarditis

38.54%

53.64%

1.85

1.51-2.26

<0.0001

Factors significantly associated with only Pleurisy

Age at SLE Diagnosis

Pleurisy

33.44±13.54

31.03±12.01

 

 

<0.0001

Factors significantly associated with both Pericarditis and Pleurisy

None

 

 

 

 

 

 

 

 

Table 2. Clinical and Laboratory Features Associated with Serositis in SLE (p<0.0001)

Characteristics

Subgroup

Negative

Positive

OR

95% CI

P-value

Factors significantly associated with only Pericarditis

Proteinuria

Pericarditis

40.37%

57.36%

1.99

1.63-2.42

<0.0001

Nephrotic Syndrome

Pericarditis

15.33%

26.78%

2.02

1.60-2.55

<0.0001

Seizure

Pericarditis

8.23%

14.31%

1.86

1.39-2.50

<0.0001

Factors significantly associated with only Pleurisy

Arthritis

Pleurisy

66.32%

79.48%

1.97

1.63-2.37

<0.0001

Arthralgia

Pleurisy

87.66%

95.85%

3.25

2.30-4.60

<0.0001

Malar Rash

Pleurisy

45.75%

54.26%

1.41

1.20-1.65

<0.0001

Factors significantly associated with both Pericarditis and Pleurisy

Fever

Pericarditis

32.60%

50.76%

2.13

1.75-2.60

<0.0001

Pleurisy

29.39%

45.95%

2.04

1.72-2.42

<0.0001

Lymphadenopathy

Pericarditis

28.35%

41.79%

1.81

1.48-2.22

<0.0001

Pleurisy

26.34%

37.78%

1.7

1.43-2.02

<0.0001

Raynaud’s Syndrome

Pericarditis

48.90%

63.34%

1.81

1.48-2.21

<0.0001

Pleurisy

47.08%

58.37%

1.58

1.34-1.86

<0.0001

Hemolytic Anemia

Pericarditis

8.34%

16.37%

2.15

1.61-2.87

<0.0001

Pleurisy

7.91%

12.87%

1.72

1.31-2.26

<0.0001

 

 

Table 3. Serologic Features Associated with Serositis in SLE (p<0.0001)

Characteristics

Subgroup

Negative

Positive

OR

95% CI

P-value

Factors significantly associated with only Pericarditis

Anti-RNP

Pericarditis

25.89%

37.82%

1.74

1.41-2.14

<0.0001

Anti-Sm

Pericarditis

17.97%

28.80%

1.85

1.47-2.32

<0.0001

Factors significantly associated with only Pleurisy

None

 

 

 

 

 

 

Factors significantly associated with both Pericarditis and Pleurisy

Anti-DNA

Pericarditis

58.74%

73.09%

1.91

1.54-2.36

<0.0001

Pleurisy

58.01%

66.99%

1.47

1.24-1.74

<0.0001

Low C3

Pericarditis

51.86%

65.46%

1.76

1.44-2.15

<0.0001

Pleurisy

50.81%

60.10%

1.46

1.24-1.72

<0.0001

Low C4

Pericarditis

44.85%

57.63%

1.67

1.38-2.04

<0.0001

Pleurisy

43.77%

52.75%

1.43

1.22-1.69

<0.0001

ESR

Pericarditis

71.71%

83.85%

2.05

1.59-2.64

<0.0001

Pleurisy

70.40%

79.51%

1.63

1.35-1.98

<0.0001

Conclusion: Pleurisy is more common than pericarditis. There are specific associates of pericarditis (African-American ethnicity, renal lupus, seizure, anti-RNP and anti-Sm) and pleurisy (arthritis). This challenges the dogma that serositis has one mechanism in SLE.

 


Disclosure: S. Ryu, None; M. Petri, None.

To cite this abstract in AMA style:

Ryu S, Petri M. Associates of Pleurisy of Pericarditis in Systemic Lupus Erythematosus (SLE) [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/associates-of-pleurisy-of-pericarditis-in-systemic-lupus-erythematosus-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associates-of-pleurisy-of-pericarditis-in-systemic-lupus-erythematosus-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology